Magnesium
MineralAlso known as: Mg · Magnesium Glycinate · Magnesium Threonate
An essential mineral involved in over 300 enzymatic reactions. Widely studied for sleep, anxiety, and metabolic health.
How expert claims hold up
42 of 42 claims assessed5 of 42 assessed claims supported or partially supported by published research
Evidence Summary
Several important caveats limit how confidently these findings can be applied. Most studies are conducted in specific populations — older adults, people with diabetes, or individuals under elevated stress — making it difficult to extrapolate benefits to the general healthy adult population. The RCT evidence is of moderate quality overall, and a large proportion of claims reviewed lacked sufficient direct support in this literature set. The bioavailability of different magnesium forms varies, but head-to-head comparisons of specific forms for specific outcomes (e.g., magnesium threonate for sleep in healthy adults) remain limited. Key questions about optimal dosing, duration of supplementation, and whether benefits persist long-term remain inadequately answered by the current evidence base.
Read full evidence summary →Top studies
Health aspects of vegan diets among children and adolescents: a systematic review and meta-analyses.
Health aspects of vegan diets among children and adolescents: a systematic review and meta-analyses.
Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis.
Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis.
Expert Mentions
All 42 mentions"if you have kidney disease or any kidney issues, you should consult a doctor before supplementing with magnesium, because impaired kidney function can lead to magnesium accumulation and that can actually be dangerous."
People with kidney disease or kidney issues should consult a doctor before supplementing with magnesium, because impaired kidney function can lead to dangerous magnesium accumulation.
None of the 10 provided studies directly address magnesium supplementation in the context of kidney disease or impaired renal clearance of magnesium. The research spans topics such as anxiety, stress, insomnia, exercise performance, and skeletal health, but none examine hypermagnesemia risk or renal contraindications. While the claim is well-established in clinical nephrology literature and pharmacology, the specific evidence provided here cannot support or contradict it.
"Magnesium oxide, for example, is cheap and commonly available, but it's not well absorbed and is going to cause GI distress in many people."
Magnesium oxide is not well absorbed and is likely to cause gastrointestinal distress in many people.
While the claim about magnesium oxide's poor bioavailability and GI side effects is widely cited in pharmacology literature, none of the 10 provided studies directly address magnesium oxide's absorption or gastrointestinal tolerability as a primary outcome. The most relevant study (PMID: 34111673), a strong-quality systematic review on magnesium supplement bioavailability, could potentially address this claim directly, but no key findings are reported in the provided data. The remaining studies focus on magnesium's effects on anxiety, sleep, exercise, and migraine without specifying outcomes related to oxide form tolerability.
Key findings
- ·A systematic review and meta-analysis found oral magnesium supplementation may improve insomnia outcomes in older adults, providing partial support for sleep-related claims — though evidence in younger, healthy populations is weaker.
- ·A meta-analysis of double-blind RCTs found magnesium supplementation can improve glucose metabolism parameters in people with or at risk of diabetes, suggesting metabolic benefits in higher-risk populations.
- ·Systematic reviews on anxiety and stress report suggestive benefits, but findings are not strong or consistent enough to draw firm conclusions.
Evidence gaps
- ·Very little high-quality RCT evidence exists for magnesium supplementation in healthy, non-deficient younger adults — most benefit data comes from older adults or people with underlying metabolic conditions.
- ·Direct comparative trials between specific magnesium forms (e.g., glycinate vs. threonate vs. malate) for outcomes like sleep quality are lacking, making form-specific recommendations largely unsupported by the available evidence.
- ·Long-term safety and efficacy data beyond short-duration trials are scarce across most health domains studied.